Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych MEQs / SAQsEmergency psychiatry

Psych MEQs / SAQs · Emergency psychiatry

Acute agitation and toxidrome emergency — assessment and management (MEQ)

FRANZCP-style MEQ on psychiatric emergency: safety, medical mimics, RT ladder with the IM olanzapine–parenteral benzodiazepine ban, serotonin vs NMS thinking, capacity/least-restrictive care, and disposition.

20 marks20 min
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 31-year-old man with schizophrenia is brought to ED after 2 days of increasing paranoia. He is pacing, shouting, diaphoretic and threatening staff. Temperature 37.0 C, HR 110, BP 148/92, SpO2 98 percent, glucose 5.8 mmol per litre. He refuses oral medication. Collateral reveals he restarted olanzapine 20 mg daily 5 days ago after a 3-month gap; family also found empty packets of an SSRI belonging to his partner. Thirty minutes after IM olanzapine 10 mg he remains agitated; a junior doctor proposes immediate IM lorazepam 2 mg. Separately, nursing notes document intermittent ankle clonus. (i) Outline your immediate assessment priorities including safety and medical exclusion. (ii) Critique the proposed IM lorazepam and state a safer RT plan with named doses and monitoring. (iii) Construct a differential for his presentation including toxidromes with discriminators. (iv) Outline capacity and least-restrictive legal principles for treatment. (v) State your disposition algorithm once he is calmer. (20 marks)

Model answer

Reveal model answer

(i) Immediate assessment. Scene safety (staff numbers, exit routes, remove weapons/audience), one calm lead communicator, de-escalation. ABCDE already partly reassuring (afebrile, oxygenating) but continue continuous observation. Focused history: substance use, overdose, head injury, seizure, medication timeline (olanzapine restart; possible SSRI exposure). MSE: threat content, command hallucinations, suicidality, attention. Collateral. Targeted medical clearance: ECG QTc, U&E, CK if restraint/exertion, consider toxicology panel if overdose suspected — clearance is risk-based, not ritualistic.[3][1]

(ii) RT plan and the proposed IM lorazepam. Do not give IM lorazepam immediately after IM olanzapine. Parenteral benzodiazepine within an hour of IM olanzapine risks profound respiratory depression and hypotension. Safer plan: continue de-escalation and environmental control; wait at least 1 hour with SpO2 and conscious-level monitoring after olanzapine; if still dangerous, senior review; options thereafter include a non-olanzapine pathway guided by local protocol (for example careful IM lorazepam only after the mandatory interval and monitoring, or alternative agents such as IM aripiprazole, or second-line IM haloperidol 5 mg + promethazine 25–50 mg if cardiac risk allows). Post-sedation monitoring every 15 minutes for at least 1 hour.[1]

(iii) Differential with discriminators. Primary psychotic relapse with agitation after non-adherence then high-dose restart. Stimulant intoxication (mydriasis, tachycardia — less clonus-specific). Early NMS (usually days, lead-pipe rigidity, bradyreflexia, fever — less likely while afebrile but watch). Serotonin toxicity if SSRI was taken with other serotonergics: hours-onset, clonus/hyperreflexia (Hunter criteria) — clonus already noted is a red flag; stop serotonergics and use benzodiazepines once safe relative to olanzapine timing; involve toxicology.[2] Delirium from medical cause if attention fluctuates later. Excited catatonia if purposeless motor signs dominate.

(iv) Capacity and law. Assess capacity for the specific decisions (accepting oral meds, remaining for assessment): understand, retain, use/weigh, communicate. Psychosis may impair capacity but does not automatically erase it for every decision. If incapacitous and serious risk, consider involuntary pathway under local statute, documenting least-restrictive alternatives tried (voluntary stay, oral meds, family support). Do not invent section numbers for other jurisdictions.[4]

(v) Disposition. If medical toxicity suspected → remain under ED/medical with psych liaison. If primary psychosis with high violence risk and incapacity → inpatient psychiatry (voluntary if possible; involuntary if criteria met). If risk falls with supports and means restriction and capacity regained → discharge only with timed follow-up, crisis contacts, and documented safety plan. Handover quality is part of the answer.[1]

Common errors

  • Co-administering IM olanzapine and IM lorazepam
  • Ignoring clonus as a serotonin red flag
  • Skipping ABCDE because “he is a psych patient”
  • Inventing Mental Health Act sections
  • Discharging without means restriction or follow-up timing
[1]

Examiner notes

Full marks require the combination ban, named alternative RT pathway with monitoring, toxidrome discriminators, capacity principles, and a disposition tree. Vague “sedate and admit” fails. [1]

References

  1. [1]Patel MX, Sethi FN, Barnes TR, et al. Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation J Psychopharmacol, 2018.PMID 29882463
  2. [2]Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity QJM, 2003.PMID 12925718
  3. [3]Anderson EL, Nordstrom K, Wilson MP, et al. American Association for Emergency Psychiatry Task Force on Medical Clearance of Adults Part I West J Emerg Med, 2017.PMID 28210358
  4. [4]Spencer BWJ, Gergel T, Hotopf M, et al. Unwell in hospital but not incapable: cross-sectional study on the dissociation of decision-making capacity for treatment and research in in-patients with schizophrenia and related psychoses. Br J Psychiatry, 2018.PMID 29909778